RecruitingNot ApplicableNCT07357818

Effects of Caffeinated Beverages on Well-being

A Randomized, Decentralized, Crossover, Open-Label Trial to Assess Subjective and Physiological Responses to Consumption of Caffeinated Beverages in Healthy Adults With a Caffeine Routine


Sponsor

GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.

Enrollment

150 participants

Start Date

Nov 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria10

  • Males or females, ≥18 to ≤55 years of age
  • BMI ≥18.5 and \<29.9 kg/m2
  • Generally good health
  • Participant currently and consistently has a caffeine routine
  • Participant is willing to substitute their current caffeine routine for the test beverage daily
  • Participant has never consumed the test beverage or similar products
  • Participant currently owns a wearable and is willing to use and connect the wearable device
  • Willing to use personal smart phone, tablet, or personal computer with stable internet connection
  • Willing and able to comply with all study procedures
  • Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study

Exclusion Criteria21

  • History or presence, on the basis of the health history, of clinically important condition or disease states
  • Is currently following, or planning to be on, a weight loss regimen
  • Weight loss or gain \>4.5 kg
  • History of gastrointestinal surgery for weight reducing purposes or gastrointestinal (GI) conditions
  • History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator.
  • History of unconventional sleep patterns (e.g., night shift) or diagnosed sleep disorder
  • Use of tobacco/nicotine products
  • Use of hemp/marijuana products
  • Unstable use of any prescription medication
  • Use of any medications(s) or dietary supplement(s), containing caffeine, or interacting with caffeine
  • Recent history of alcohol or substance abuse
  • Exposed to any non-registered drug product
  • Self-report of hypertension/high blood pressure without use of hypertensive medications
  • Any known allergy or intolerance to any ingredients contained in the study product
  • Any signs or symptoms of active infection of clinical relevance
  • History or presence of cancer, except for non-melanoma skin cancer
  • History of any major trauma or major surgical event
  • Female who is pregnant, planning to be pregnant during the study period, lactating
  • An employee, close relative of an employee, or participant who has a financial interest in Sponsor company or any other caffeine beverage company.
  • Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol
  • A clinically significant medical condition that is affected by caffeine

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERParticipants' typical caffeinated beverage

Participants will consume the caffeinated beverage they typically consume.

OTHERTest caffeinated beverage

Participants will consume a test beverage that contains caffeine.


Locations(1)

Alethios, Inc.

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07357818


Related Trials